Please wait a minute...
文章检索
预防医学  2021, Vol. 33 Issue (6): 551-557    DOI: 10.19485/j.cnki.issn2096-5087.2021.06.003
  论著 本期目录 | 过刊浏览 | 高级检索 |
河北省成年居民物质所致精神障碍的影响因素分析
贾宏学1, 张云淑2, 栗克清2
1.河北大学公共卫生学院,河北 保定 071000;
2.河北省精神卫生中心科教处
Influencing factors for substance-induced psychotic disorders among adultsin Hebei Province
JIA Hongxue, ZHANG Yunshu, LI Keqing
College of Public Health, Hebei University, Baoding, Hebei 071000, China
全文: PDF(902 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解河北省成年居民物质所致精神障碍情况,并分析其影响因素,为制订物质所致精神障碍防制策略提供依据。方法 采用多阶段分层随机抽样方法,在河北省城市和农村逐层选取≥18岁常住居民为调查对象,采用自行设计的一般情况问卷收集人口学资料,采用一般健康问卷12项(GHQ-12)和8个有关精神障碍危险因素问卷收集物质所致精神障碍情况;采用多因素Logistic回归模型分析物质所致精神障碍的影响因素。结果 发放问卷23 675份,回收有效问卷20 884份,回收有效率为88.21%。居民物质所致精神障碍终生患病率加权后为6.20%,其中酒精、镇静剂/催眠药/抗焦虑药和其他物质所致精神障碍的终生患病率加权后分别为5.93%、0.24%和0.04%。多因素Logistic回归分析结果显示,年龄(35~<45岁,OR=1.582,95%CI:1.091~2.292;45~<60岁,OR=2.185,95%CI:1.524~3.132;≥60岁,OR=2.061,95%CI:1.422~2.986)、男性(OR=10.832,95%CI:8.265~14.196)、居住在城市(OR=1.431,95%CI:1.202~1.703)、非贫困家庭(OR=2.291,95%CI:1.652~3.177)、有躯体疾病(OR=2.028,95%CI:1.678~2.452)和有遗传病史(OR=1.574,95%CI:1.181~2.098)与物质所致精神障碍存在统计学关联。结论 河北省成年居民物质所致精神障碍终生患病率为6.20%,患病风险与年龄、性别、地区、家庭经济状况、躯体疾病史和遗传病史相关。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
贾宏学
张云淑
栗克清
关键词 物质所致精神障碍患病率影响因素    
AbstractObjective To investigate the status and influencing factors of substance-induced psychotic disorders in residents over 18 years old in Hebei Province, and to provide evidence for the prevention and control of substance-induced psychotic disorders. Methods Using multi-stage stratified random sampling method, the permanent residents aged 18 years and over were selected from urban and rural areas in Hebei Province. The demographic data was collected, the 12-Item General Health Questionnaire ( GHQ-12 ) and eight risk factors about mental disorder questionnaire were used to find out mental disorders. The multivariate logistic regression model was conducted to analyze the influencing factor for substance-induced psychotic disorders. Results A total of 23 675 questionnaires were sent out, 20 884 were valid ( 88.20% ).The weighted lifetime prevalence rates of substance-induced psychotic disorders, alcohol-related disorders, sedatives/hypnotics/anti-anxiety disorders and other substance-induced psychotic disorders were 6.20%, 5.93%, 0.24% and 0.04%, respectively. Multivariate logistic regression analysis showed that age ( 35-<45, OR=1.582, 95%CI: 1.091-2.292; 45-<60, OR=2.185, 95%CI: 1.524-3.132; ≥60, OR=2.061, 95%CI: 1.422-2.986 ), males ( OR=10.832, 95%CI: 8.265-14.196 ), urban area (OR=1.431, 95%CI: 1.202-1.703 ), non-poor family ( OR=2.291, 95%CI: 1.652-3.177 ), physical diseases ( OR=2.028, 95%CI: 1.678-2.452 ) and genetic history ( OR=1.574, 95%CI:1.181-2.098 ) were the influencing factors for substance-induced psychotic disorders. Conclusion The lifetime prevalence of substance-induced psychotic disorders among residents aged 18 years and over in Hebei Province is 6.20%, which is mainly related to age, gender, region, family economic situation, physical disease history and genetic history.
Key wordssubstance-induced psychotic disorders    prevalence    influencing factors
收稿日期: 2020-11-30      修回日期: 2021-03-10     
中图分类号:  R179  
基金资助:河北省重点研发计划(182777194)
作者简介: 贾宏学,硕士,主要从事精神障碍流行病学调查工作
通信作者: 栗克清,E-mail:like1002@sina.com   
引用本文:   
贾宏学, 张云淑, 栗克清. 河北省成年居民物质所致精神障碍的影响因素分析[J]. 预防医学, 2021, 33(6): 551-557.
JIA Hongxue, ZHANG Yunshu, LI Keqing. Influencing factors for substance-induced psychotic disorders among adultsin Hebei Province. Preventive Medicine, 2021, 33(6): 551-557.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2021.06.003      或      https://www.zjyfyxzz.com/CN/Y2021/V33/I6/551
[1] KUNREUTHER E.Autism spectrum disorder and substance use disorder:a dual diagnosis hiding in plain sight[J].Child Adolesc Psychiatr Clin N Am,2020,29(3):467-481.
[2] ZHANG H X,JI J L.Prevalence of mental disorders in China[J].Lancet Psychiatry,2019,6(3):188-189.
[3] 栗克清,崔泽,崔利军,等.河北省精神障碍的现况调查[J].中华精神科杂志,2007,40(1):36-40.
[4] 李建彬,高莉,郭向娇,等.郑州市居民二手烟暴露及危害认知情况调查[J].预防医学,2020,32(5):455-459.
[5] ANJARA S G, BONETTO C, BORTEL T V, et al.Using the GHQ-12 to screen for mental health problems among primary care patients: psychometrics and practical considerations[J].Int J Ment Health Syst,2020,14(1):1-7.
[6] PHILLIPS M R,ZHANG J X,SHI Q C,et al.Prevalence,treatment, and associated disability of mental disorders in four provinces in China during 2001-2005: an epidemiological survey[J].Lancet,2009,373(9680):2041-2053.
[7] VENTURA J, LIBERMAN R P, GREEN M F, et al.Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P)[J].Psychiatry Res,1998,79(2):163-173.
[8] ZHANG Y S, RAO W W, CUI L J, et al.Prevalence of major depressive disorder and its socio-demographic correlates in the general adult population in Hebei province,China[J].J Affect Disord,2019,252:92-98.
[9] 金金,何燕玲,周亮,等.精神病症状维度评定量表中文版的效度和信度[J].中国心理卫生杂志,2020,34(11):932-939.
[10] HUANG Y Q,WANG Y,WANG H,et al.Prevalence of mental disorders in China: a cross-sectional epidemiological study[J].Lancet Psychiatry,2019,6(3):211-224.
[11] 李建华. 我国物质成瘾心理行为治疗的现状、挑战及应对策略[J].中国药物滥用防治杂志,2019,25(2):76-81.
[12] 田国娇,张炳智,高茹,等.芦山4·20地震5年后雅安地区酒精使用障碍流行病学调查[J].中国药物依赖性杂志,2020,29(6):469-473.
[13] 廖震华,王文强,丁丽君,等.厦门市不同人群心境障碍、焦虑障碍和物质相关精神障碍现况调查[J].中国职业医学,2014,41(1):46-51.
[14] 石锦娟. 陕西、河南、甘肃三省精神障碍流行病学调查及对比分析[D].西安:第四军医大学,2015.
[15] MCHUGH R K,GEYER R B,CHASE A R,et al.Sex differences in benzodiazepine misuse among adults with substance use disorders.[J/OL].Addict Behav,2021,112:106608[2021-03-10].https://www.sciencedirect.com/science/article/abs/pii/S0306460320307383?via%3Dihub.DOI:10.1016/j.addbeh.2020.106608.
[16] ANDERSSON H W,NORDFJÆRN T.Factors associated with quality of life trajectories among inpatients treated for alcohol use disorders:a prospective cohort study.[J/OL].Addict Behav Rep,2020,12:100285[2021-03-10].https://www.sciencedirect.com/science/article/pii/S2352853220301000?via%3Dihub.DOI:10.1016/j.abrep.2020.100285
[17] 李凤娟,孙经,何健,等.河南省青少年物质成瘾行为现况及影响因素分析[J].中国公共卫生,2018,34(4):497-500.
[18] 润海燕,李英,王爱民,等.苯丙胺类、阿片类和酒依赖者住院后结局与影响因素研究[J].内蒙古医学杂志,2020,52(5):516-520.
[1] 吕婧, 徐欣颖, 乔颖异, 石兴龙, 岳芳, 刘营, 程传龙, 张宇琦, 孙继民, 李秀君. 浙江省发热伴血小板减少综合征流行特征及影响因素分析[J]. 预防医学, 2026, 38(1): 10-14.
[2] 吴成慧, 彭艳红, 张可, 朱维晔, 邓亮, 谭玲玲, 瞿丹丹, 米秋香. 中青年2型糖尿病患者益处发现的影响因素分析[J]. 预防医学, 2026, 38(1): 31-35.
[3] 徐光明, 张震, 叶小红. 2015—2024年临海市新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2026, 38(1): 71-74.
[4] 夏子淇, 陈晴晴, 高四海, 吴矛矛. 温州市中小学生营养健康知识调查[J]. 预防医学, 2026, 38(1): 98-101,106.
[5] 陈慧, 苗姗姗, 刘宪峰, 张慧. 新疆生产建设兵团中小学生龋齿现况调查[J]. 预防医学, 2026, 38(1): 102-106.
[6] 陶桃, 张海芳, 凡鹏飞, 李秋华, 陈晓蕾. 丽水市老年肺结核患者治疗转归的影响因素分析[J]. 预防医学, 2025, 37(9): 892-896,902.
[7] 徐艳平, 闫晓彤, 姚丁铭, 徐越, 张雪海, 孙洁, 徐锦杭. 浙江省中老年人肺炎疫苗接种意愿的影响因素研究[J]. 预防医学, 2025, 37(9): 881-885.
[8] 姜艳, 李锦成, 许纯, 杨科佼, 杨文彬, 徐胜. 扬州市MSM人群艾滋病非职业暴露后预防知晓率调查[J]. 预防医学, 2025, 37(9): 903-906,912.
[9] 翟羽佳, 章涛, 古雪, 徐乐, 吴梦娜, 林君芬, 吴晨. 社区老年人认知衰弱现况调查[J]. 预防医学, 2025, 37(8): 762-766,772.
[10] 苏德华, 陈向阳, 李君, 赵丽娜, 张鹤美, 朱婷婷, 胡文雪, 赖江宜. 温州市新报告HIV/AIDS病例抗病毒治疗及时性分析[J]. 预防医学, 2025, 37(8): 804-808.
[11] 严青秀, 王炜, 郝晓刚, 高宇, 方春福, 张幸, 刘文峰. 2017—2023年衢州市肺结核患者未收治情况分析[J]. 预防医学, 2025, 37(8): 799-803.
[12] 王晓宇, 张志平, 董玉颖, 梁杰, 陈强. 老年人带状疱疹疫苗接种意愿的影响因素分析[J]. 预防医学, 2025, 37(8): 809-813.
[13] 王海琪, 张涵潇, 杨凤云, 国献丽, 范生荣, 张丽锋, 蒋泓. 嘉定区中学生抑郁情绪调查[J]. 预防医学, 2025, 37(8): 832-836.
[14] 成灵灵, 阎亚琼, 白增华, 张晓刚, 郝丽婷, 杨慧莹. 先天性甲状腺功能减退症患儿年龄别体质指数Z评分变化轨迹及影响因素[J]. 预防医学, 2025, 37(8): 858-863.
[15] 王立新, 王浩, 何青芳, 方雨葭, 张洁, 杜晓甫. 浙江省居民限盐勺使用情况调查[J]. 预防医学, 2025, 37(7): 668-672.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed